Rajeev M. Shah - Net Worth and Insider Trading
Rajeev M. Shah Net Worth
The estimated net worth of Rajeev M. Shah is at least $541 Million dollars as of 2024-08-23. Rajeev M. Shah is the Director of Eidos Therapeutics Inc and owns about 2,162,671 shares of Eidos Therapeutics Inc (EIDX) stock worth over $264 Million. Rajeev M. Shah is the Director, 10% Owner of Ra Pharmaceuticals Inc and owns about 4,858,260 shares of Ra Pharmaceuticals Inc (RARX) stock worth over $233 Million. Rajeev M. Shah is also the Director, 10% Owner of KalVista Pharmaceuticals Inc and owns about 1,441,070 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $18 Million. Besides these, Rajeev M. Shah also holds Black Diamond Therapeutics Inc (BDTX) , Satsuma Pharmaceuticals Inc (STSA) , Solid Biosciences Inc (SLDB) , Kala Bio Inc (KALA) . Details can be seen in Rajeev M. Shah's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rajeev M. Shah has not made any transactions after 2020-03-13 and currently still holds the listed stock(s).
Transaction Summary of Rajeev M. Shah
Rajeev M. Shah Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rajeev M. Shah owns 50 companies in total, including Vaxcyte Inc (PCVX) , Cardiff Oncology Inc (CRDF) , and PMV Pharmaceuticals Inc (PMVP) among others .
Click here to see the complete history of Rajeev M. Shah’s form 4 insider trades.
Insider Ownership Summary of Rajeev M. Shah
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PCVX | Vaxcyte Inc | 2020-06-16 | 10 percent owner |
CRDF | Cardiff Oncology Inc | 2020-09-30 | 10 percent owner |
PMVP | PMV Pharmaceuticals Inc | 2020-09-24 | 10 percent owner |
![]() | ![]() | 2020-09-16 | 10 percent owner |
![]() | ![]() | 2019-11-08 | director & 10 percent owner |
![]() | ![]() | 2020-05-05 | 10 percent owner |
![]() | ![]() | 2020-08-18 | 10 percent owner |
![]() | ![]() | 2020-07-23 | 10 percent owner |
![]() | ![]() | 2020-07-23 | 10 percent owner |
![]() | ![]() | 2020-07-21 | 10 percent owner |
![]() | ![]() | 2020-07-09 | 10 percent owner |
![]() | ![]() | 2020-06-25 | 10 percent owner |
![]() | ![]() | 2020-06-25 | 10 percent owner |
![]() | ![]() | 2020-03-13 | director |
![]() | ![]() | 2020-03-03 | 10 percent owner |
![]() | ![]() | 2020-06-18 | 10 percent owner |
![]() | ![]() | 2018-01-30 | director |
![]() | ![]() | 2019-09-17 | director & 10 percent owner |
![]() | ![]() | 2020-05-27 | director |
![]() | ![]() | 2020-04-02 | director & 10 percent owner |
![]() | ![]() | 2019-10-25 | 10 percent owner |
![]() | ![]() | 2020-03-11 | 10 percent owner |
![]() | ![]() | 2020-02-14 | 10 percent owner |
![]() | ![]() | 2020-02-03 | director |
![]() | ![]() | 2020-01-23 | 10 percent owner |
![]() | ![]() | 2017-10-12 | director |
![]() | ![]() | 2021-08-03 | 10 percent owner |
![]() | ![]() | 2021-06-30 | director & 10 percent owner |
![]() | ![]() | 2020-12-07 | 10 percent owner |
![]() | ![]() | 2021-04-01 | 10 percent owner |
![]() | ![]() | 2021-09-14 | director & 10 percent owner |
![]() | ![]() | 2020-11-22 | 10 percent owner |
![]() | ![]() | 2020-08-06 | 10 percent owner |
![]() | ![]() | 2021-08-09 | director & 10 percent owner |
![]() | ![]() | 2021-04-29 | director & 10 percent owner |
![]() | ![]() | 2021-07-28 | director & 10 percent owner |
![]() | ![]() | 2021-06-29 | director & 10 percent owner |
![]() | ![]() | 2021-06-23 | director |
![]() | ![]() | 2021-02-04 | director & 10 percent owner |
![]() | ![]() | 2021-06-10 | director & 10 percent owner |
![]() | ![]() | 2021-07-22 | director |
![]() | ![]() | 2022-05-05 | director & 10 percent owner |
![]() | ![]() | 2021-09-14 | director & 10 percent owner |
![]() | ![]() | 2022-03-24 | 10 percent owner |
![]() | ![]() | 2022-08-16 | 10 percent owner |
![]() | ![]() | 2022-11-08 | director |
![]() | ![]() | 2022-11-09 | director & 10 percent owner |
![]() | ![]() | 2022-11-08 | director |
![]() | ![]() | 2020-03-11 | 10 percent owner |
![]() | ![]() | 2023-02-09 | director & 10 percent owner |
Rajeev M. Shah Latest Holdings Summary
Rajeev M. Shah currently owns a total of 7 stocks. Among these stocks, Rajeev M. Shah owns 2,162,671 shares of Eidos Therapeutics Inc (EIDX) as of June 22, 2018, with a value of $264 Million and a weighting of 48.89%. Rajeev M. Shah owns 4,858,260 shares of Ra Pharmaceuticals Inc (RARX) as of December 14, 2018, with a value of $233 Million and a weighting of 43.13%. Rajeev M. Shah also owns 1,441,070 shares of KalVista Pharmaceuticals Inc (KALV) as of October 12, 2017, with a value of $18 Million and a weighting of 3.37%. The other 4 stocks Black Diamond Therapeutics Inc (BDTX) , Satsuma Pharmaceuticals Inc (STSA) , Solid Biosciences Inc (SLDB) , Kala Bio Inc (KALA) have a combined weighting of 4.61% among all his current holdings.
Latest Holdings of Rajeev M. Shah
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EIDX | Eidos Therapeutics Inc | 2018-06-22 | 2,162,671 | 122.21 | 264,300,023 |
RARX | Ra Pharmaceuticals Inc | 2018-12-14 | 4,858,260 | 47.99 | 233,147,897 |
KALV | KalVista Pharmaceuticals Inc | 2017-10-12 | 1,441,070 | 12.63 | 18,200,714 |
BDTX | Black Diamond Therapeutics Inc | 2020-02-03 | 2,589,904 | 6.46 | 16,730,780 |
STSA | Satsuma Pharmaceuticals Inc | 2019-09-17 | 4,681,858 | 1.10 | 5,150,044 |
SLDB | Solid Biosciences Inc | 2018-01-30 | 179,296 | 9.56 | 1,714,070 |
KALA | Kala Bio Inc | 2020-03-13 | 217,492 | 6.01 | 1,307,127 |
Holding Weightings of Rajeev M. Shah
Rajeev M. Shah Form 4 Trading Tracker
According to the SEC Form 4 filings, Rajeev M. Shah has made a total of 0 transactions in Eidos Therapeutics Inc (EIDX) over the past 5 years. The most-recent trade in Eidos Therapeutics Inc is the acquisition of 1,058,824 shares on June 22, 2018, which cost Rajeev M. Shah around $18 Million.
According to the SEC Form 4 filings, Rajeev M. Shah has made a total of 0 transactions in Ra Pharmaceuticals Inc (RARX) over the past 5 years. The most-recent trade in Ra Pharmaceuticals Inc is the acquisition of 1,006,452 shares on December 14, 2018, which cost Rajeev M. Shah around $16 Million.
According to the SEC Form 4 filings, Rajeev M. Shah has made a total of 0 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years. The most-recent trade in KalVista Pharmaceuticals Inc is the acquisition of 850,000 shares on October 12, 2017, which cost Rajeev M. Shah around $7 Million.
More details on Rajeev M. Shah's insider transactions can be found in the Insider Trading History of Rajeev M. Shah table.Insider Trading History of Rajeev M. Shah
- 1
Rajeev M. Shah Trading Performance
GuruFocus tracks the stock performance after each of Rajeev M. Shah's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rajeev M. Shah is 3.63%. GuruFocus also compares Rajeev M. Shah's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rajeev M. Shah within 3 months outperforms 5 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rajeev M. Shah's insider trading performs compared to the benchmark.
Performance of Rajeev M. Shah
Rajeev M. Shah Ownership Network
Rajeev M. Shah Owned Company Details
What does Vaxcyte Inc do?
Who are the key executives at Vaxcyte Inc?
Rajeev M. Shah is the 10 percent owner of Vaxcyte Inc. Other key executives at Vaxcyte Inc include CFO & CBO Andrew Guggenhime , SVP & Gen Counsel & Corp Sec Mikhail Eydelman , and Chief Operating Officer Jim Wassil .
Vaxcyte Inc (PCVX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 176,168 shares made by Grant Pickering , a net sale of 102,000 shares made by Andrew Guggenhime , and a net sale of 30,000 shares made by Jim Wassil .
In summary, during the past 3 months, insiders sold 101,433 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 101,433 shares. During the past 18 months, 397,048 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 397,048 shares.
Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vaxcyte Inc Insider Transactions
- Download to Excel(.xls)
What does Cardiff Oncology Inc do?
Who are the key executives at Cardiff Oncology Inc?
Rajeev M. Shah is the 10 percent owner of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Medical Officer Fairooz Kabbinavar , Chief Scientific Officer Mark Erlander , and Chief Financial Officer James E. Levine .
Cardiff Oncology Inc (CRDF) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 52,950 shares made by Gary W Pace ,
In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 52,950 shares were bought by its insiders, resulting in a net purchase of 52,950 shares.
Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiff Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does PMV Pharmaceuticals Inc do?
Who are the key executives at PMV Pharmaceuticals Inc?
Rajeev M. Shah is the 10 percent owner of PMV Pharmaceuticals Inc. Other key executives at PMV Pharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , Chief Medical Officer Leila Alland , and SVP & Regulatory Affairs and QA Deepika Jalota .
PMV Pharmaceuticals Inc (PMVP) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 87,786 shares made by Orbimed Advisors Llc , a net sale of 6,291 shares made by Leila Alland , and a net sale of 4,104 shares made by Deepika Jalota .
In summary, during the past 3 months, insiders sold 0 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 98,181 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 98,181 shares.
PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.
PMV Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include director & 10 percent owner Dirk Kersten , See Remarks Richard William Scalzo , and Chief Medical Officer Wildon Farwell .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 199,895 shares made by Richard William Scalzo , a net sale of 260,996 shares made by Susanna Gatti High , and a net sale of 208,005 shares made by Jonathan Mcneill .
In summary, during the past 3 months, insiders sold 1,561,024 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 1,561,024 shares. During the past 18 months, 7,031,224 shares of Dyne Therapeutics Inc (DYN) were sold and 1,714,285 shares were bought by its insiders, resulting in a net sale of 5,316,939 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does 89bio Inc do?
Who are the key executives at 89bio Inc?
Rajeev M. Shah is the director & 10 percent owner of 89bio Inc. Other key executives at 89bio Inc include director & Chief Executive Officer Rohan Palekar , director & 10 percent owner Ra Capital Healthcare Fund Lp , and See Remarks Quoc Le-nguyen .
89bio Inc (ETNB) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in 89bio Inc (ETNB). Other recent insider transactions involving 89bio Inc (ETNB) include a net sale of 87,195 shares made by Rohan Palekar , a net purchase of 3,811,538 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 13,721 shares made by Ryan Martins .
In summary, during the past 3 months, insiders sold 0 shares of 89bio Inc (ETNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,349 shares of 89bio Inc (ETNB) were sold and 3,899,326 shares were bought by its insiders, resulting in a net purchase of 3,765,977 shares.
89bio Inc (ETNB)'s detailed insider trading history can be found in Insider Trading Tracker table.
89bio Inc Insider Transactions
- Download to Excel(.xls)
What does TG Therapeutics Inc do?
Who are the key executives at TG Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of TG Therapeutics Inc. Other key executives at TG Therapeutics Inc include CFO & Secretary and Treasurer Sean A Power , director & CEO and President Michael S Weiss , and 10 percent owner Ra Capital Management, L.p. .
TG Therapeutics Inc (TGTX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in TG Therapeutics Inc (TGTX). Other recent insider transactions involving TG Therapeutics Inc (TGTX) include a net sale of 65,787 shares made by Sagar Lonial , a net sale of 121,514 shares made by Sean A Power , and a net sale of 39,500 shares made by Laurence N Charney .
In summary, during the past 3 months, insiders sold 25,933 shares of TG Therapeutics Inc (TGTX) in total and bought 0 shares, with a net sale of 25,933 shares. During the past 18 months, 226,801 shares of TG Therapeutics Inc (TGTX) were sold and 100,000 shares were bought by its insiders, resulting in a net sale of 126,801 shares.
TG Therapeutics Inc (TGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
TG Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Inhibrx Inc do?
Who are the key executives at Inhibrx Inc?
Rajeev M. Shah is the 10 percent owner of Inhibrx Inc. Other key executives at Inhibrx Inc include director & 10 percent owner & Chief Scientific Officer Brendan P. Eckelman , 10 percent owner Ole Andreas Halvorsen , and 10 percent owner Viking Global Opportunities Parent Gp Llc .
Inhibrx Inc (INBX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Inhibrx Inc (INBX). Other recent insider transactions involving Inhibrx Inc (INBX) include a net purchase of 511,627 shares made by Viking Global Investors Lp , a net sale of 300,000 shares made by Brendan P. Eckelman , and a net sale of 60 shares made by Mark Lappe .
In summary, during the past 3 months, insiders sold 300,000 shares of Inhibrx Inc (INBX) in total and bought 0 shares, with a net sale of 300,000 shares. During the past 18 months, 300,060 shares of Inhibrx Inc (INBX) were sold and 511,627 shares were bought by its insiders, resulting in a net purchase of 211,567 shares.
Inhibrx Inc (INBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibrx Inc Insider Transactions
- Download to Excel(.xls)
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Rajeev M. Shah is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and 10 percent owner Longitude Capital Partners Iii, Llc .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does ITeos Therapeutics Inc do?
Who are the key executives at ITeos Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of ITeos Therapeutics Inc. Other key executives at ITeos Therapeutics Inc include Chief Financial Officer Matthew Gall , other: See remarks Joseph Lewis , and other: See remarks Boxer Asset Management Inc. .
ITeos Therapeutics Inc (ITOS) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in ITeos Therapeutics Inc (ITOS). Other recent insider transactions involving ITeos Therapeutics Inc (ITOS) include a net sale of 350,000 shares made by Boxer Capital, Llc , and a net purchase of 5,000 shares made by Matthew Gall .
In summary, during the past 3 months, insiders sold 0 shares of ITeos Therapeutics Inc (ITOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 350,000 shares of ITeos Therapeutics Inc (ITOS) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 345,000 shares.
ITeos Therapeutics Inc (ITOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
ITeos Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Pandion Therapeutics Inc do?
Who are the key executives at Pandion Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Mva Investors, Llc , and 10 percent owner Polaris Partners VIII, L.P. .
Pandion Therapeutics Inc (PAND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pandion Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Rajeev M. Shah is the 10 percent owner of Nkarta Inc. Other key executives at Nkarta Inc include Chief Legal Officer Alicia J. Hager , Chief Medical Officer David Shook , and Sr. VP & Technical Operations Ralph Brandenberger .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 9,598 shares made by James Trager , a net sale of 9,378 shares made by Alicia J. Hager , and a net sale of 5,778 shares made by David Shook .
In summary, during the past 3 months, insiders sold 7,034 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 7,034 shares. During the past 18 months, 41,413 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,958,587 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
- Download to Excel(.xls)
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Rajeev M. Shah is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 78,894 shares made by Jennifer Chien , and a net sale of 69,049 shares made by Hunter C Smith .
In summary, during the past 3 months, insiders sold 76,182 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 76,182 shares. During the past 18 months, 467,779 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 467,779 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Akouos Inc do?
Who are the key executives at Akouos Inc?
Rajeev M. Shah is the 10 percent owner of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .
Akouos Inc (AKUS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akouos Inc Insider Transactions
- Download to Excel(.xls)
What does Kala Bio Inc do?
Who are the key executives at Kala Bio Inc?
Rajeev M. Shah is the director of Kala Bio Inc. Other key executives at Kala Bio Inc include CHIEF BUSINESS OFFICER Darius Kharabi , director & Chief Executive Officer Mark T Iwicki , and Chief Financial Officer Mary Reumuth .
Kala Bio Inc (KALA) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Kala Bio Inc (KALA). Other recent insider transactions involving Kala Bio Inc (KALA) include a net sale of 27,099 shares made by Mark T Iwicki , a net sale of 9,108 shares made by Romulus K Brazzell , and a net sale of 8,151 shares made by Todd Bazemore .
In summary, during the past 3 months, insiders sold 48,135 shares of Kala Bio Inc (KALA) in total and bought 0 shares, with a net sale of 48,135 shares. During the past 18 months, 59,535 shares of Kala Bio Inc (KALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 59,535 shares.
Kala Bio Inc (KALA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kala Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Verastem Inc do?
Who are the key executives at Verastem Inc?
Rajeev M. Shah is the 10 percent owner of Verastem Inc. Other key executives at Verastem Inc include Chief Operating Officer Dan Paterson , Vice President of Finance Daniel Calkins , and Chief Financial Officer Robert E. Gagnon .
Verastem Inc (VSTM) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 1,022 shares made by Daniel Calkins , a net sale of 25,788 shares made by Robert E. Gagnon , and a net sale of 10,852 shares made by Dan Paterson .
In summary, during the past 3 months, insiders sold 5,116 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 5,116 shares. During the past 18 months, 32,180 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,180 shares.
Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verastem Inc Insider Transactions
- Download to Excel(.xls)
What does Forma Therapeutics Holdings Inc do?
Who are the key executives at Forma Therapeutics Holdings Inc?
Rajeev M. Shah is the 10 percent owner of Forma Therapeutics Holdings Inc. Other key executives at Forma Therapeutics Holdings Inc include EVP & Research & Development Agustin Melian , SVP & Chief Scientific Officer David N Cook , and SVP & Chief Financial Officer Todd Shegog .
Forma Therapeutics Holdings Inc (FMTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Forma Therapeutics Holdings Inc (FMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forma Therapeutics Holdings Inc (FMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Forma Therapeutics Holdings Inc (FMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Forma Therapeutics Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does Solid Biosciences Inc do?
Who are the key executives at Solid Biosciences Inc?
Rajeev M. Shah is the director of Solid Biosciences Inc. Other key executives at Solid Biosciences Inc include director & Chief Executive Officer Ilan Ganot , director & 10 percent owner Ra Capital Healthcare Fund Lp , and director & 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Solid Biosciences Inc (SLDB) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 2,230 shares made by Ilan Ganot , a net purchase of 3,410,713 shares made by Perceptive Life Sciences Master Fund Ltd , and a net purchase of 904,160 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 0 shares of Solid Biosciences Inc (SLDB) in total and bought 1,100 shares, with a net purchase of 1,100 shares. During the past 18 months, 24,269 shares of Solid Biosciences Inc (SLDB) were sold and 4,315,973 shares were bought by its insiders, resulting in a net purchase of 4,291,704 shares.
Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Solid Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Satsuma Pharmaceuticals Inc do?
Who are the key executives at Satsuma Pharmaceuticals Inc?
Rajeev M. Shah is the director & 10 percent owner of Satsuma Pharmaceuticals Inc. Other key executives at Satsuma Pharmaceuticals Inc include 10 percent owner Shin Nippon Biomedical Laboratories, Ltd. , director & 10 percent owner Ken Takanashi , and 10 percent owner Braden Michael Leonard .
Satsuma Pharmaceuticals Inc (STSA) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Satsuma Pharmaceuticals Inc (STSA). Other recent insider transactions involving Satsuma Pharmaceuticals Inc (STSA) include a net purchase of 30,477,313 shares made by Shin Nippon Biomedical Laboratories, Ltd. , and a net purchase of 22,053,581 shares made by Ken Takanashi .
In summary, during the past 3 months, insiders sold 0 shares of Satsuma Pharmaceuticals Inc (STSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Satsuma Pharmaceuticals Inc (STSA) were sold and 52,530,894 shares were bought by its insiders, resulting in a net purchase of 52,530,894 shares.
Satsuma Pharmaceuticals Inc (STSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Satsuma Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Eidos Therapeutics Inc do?
Who are the key executives at Eidos Therapeutics Inc?
Rajeev M. Shah is the director of Eidos Therapeutics Inc. Other key executives at Eidos Therapeutics Inc include director & Chief Scientific Officer Uma Sinha , Senior Vice President & Finance Franco Valle , and Chief Business Officer Cameron Turtle .
Eidos Therapeutics Inc (EIDX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eidos Therapeutics Inc (EIDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eidos Therapeutics Inc (EIDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eidos Therapeutics Inc (EIDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eidos Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Ra Pharmaceuticals Inc do?
Who are the key executives at Ra Pharmaceuticals Inc?
Rajeev M. Shah is the director & 10 percent owner of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & President and CEO Douglas A Treco , and 10 percent owner Scott D Sandell .
Ra Pharmaceuticals Inc (RARX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ra Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Phathom Pharmaceuticals Inc do?
Who are the key executives at Phathom Pharmaceuticals Inc?
Rajeev M. Shah is the 10 percent owner of Phathom Pharmaceuticals Inc. Other key executives at Phathom Pharmaceuticals Inc include CFO and CBO Molly Henderson , Chief Operating Officer Azmi Nabulsi , and 10 percent owner Takeda Pharmaceutical Co Ltd .
Phathom Pharmaceuticals Inc (PHAT) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Phathom Pharmaceuticals Inc (PHAT). Other recent insider transactions involving Phathom Pharmaceuticals Inc (PHAT) include a net sale of 38,227 shares made by Molly Henderson , a net sale of 39,216 shares made by Terrie Curran , and a net purchase of 8,500 shares made by Asit Parikh .
In summary, during the past 3 months, insiders sold 49,074 shares of Phathom Pharmaceuticals Inc (PHAT) in total and bought 0 shares, with a net sale of 49,074 shares. During the past 18 months, 3,804,966 shares of Phathom Pharmaceuticals Inc (PHAT) were sold and 31,419 shares were bought by its insiders, resulting in a net sale of 3,773,547 shares.
Phathom Pharmaceuticals Inc (PHAT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Phathom Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Imara Inc do?
Who are the key executives at Imara Inc?
Rajeev M. Shah is the 10 percent owner of Imara Inc. Other key executives at Imara Inc include director & President & CEO Rahul D. Ballal , See Remarks Michael Gray , and 10 percent owner Braden Michael Leonard .
Imara Inc (IMRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Imara Inc Insider Transactions
- Download to Excel(.xls)
What does scPharmaceuticals Inc do?
Who are the key executives at scPharmaceuticals Inc?
Rajeev M. Shah is the 10 percent owner of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and director & President and CEO John H Tucker .
scPharmaceuticals Inc (SCPH) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in scPharmaceuticals Inc (SCPH). Other recent insider transactions involving scPharmaceuticals Inc (SCPH) include a net purchase of 500,000 shares made by Orbimed Advisors Llc ,
In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 500,000 shares, with a net purchase of 500,000 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 500,000 shares were bought by its insiders, resulting in a net purchase of 500,000 shares.
scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
scPharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Black Diamond Therapeutics Inc do?
Who are the key executives at Black Diamond Therapeutics Inc?
Rajeev M. Shah is the director of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Biotech Growth N V , director & 10 percent owner Ali Behbahani , and director & See Remarks David M. Epstein .
Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 5,050,850 shares.
Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Black Diamond Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Synthorx Inc do?
Who are the key executives at Synthorx Inc?
Rajeev M. Shah is the 10 percent owner of Synthorx Inc. Other key executives at Synthorx Inc include 10 percent owner Ra Capital Healthcare Fund Lp , 10 percent owner Ra Capital Management, L.p. , and director & 10 percent owner Peter Kolchinsky .
Synthorx Inc (THOR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Synthorx Inc (THOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Synthorx Inc (THOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Synthorx Inc (THOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synthorx Inc Insider Transactions
- Download to Excel(.xls)
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Rajeev M. Shah is the director of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Medical Officer Paul K. Audhya , CFO and Secretary Benjamin L Palleiko , and Chief Development Officer Christopher Yea .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 137,408 shares made by Benjamin L Palleiko , and a net sale of 116,267 shares made by Edward P. Feener .
In summary, during the past 3 months, insiders sold 36,755 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 36,755 shares. During the past 18 months, 571,967 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 679,050 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does RxSight Inc do?
Who are the key executives at RxSight Inc?
Rajeev M. Shah is the 10 percent owner of RxSight Inc. Other key executives at RxSight Inc include Chief Operating Officer Ilya Goldshleger , director & See Remarks Kurtz Ronald M Md , and Chief Financial Officer Shelley B Thunen .
RxSight Inc (RXST) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in RxSight Inc (RXST). Other recent insider transactions involving RxSight Inc (RXST) include a net sale of 92,431 shares made by Ilya Goldshleger , a net sale of 1,063,606 shares made by Bakker Juliet Tammenoms , and a net sale of 50,000 shares made by Eric Weinberg .
In summary, during the past 3 months, insiders sold 24,625 shares of RxSight Inc (RXST) in total and bought 0 shares, with a net sale of 24,625 shares. During the past 18 months, 1,579,543 shares of RxSight Inc (RXST) were sold and 13,000 shares were bought by its insiders, resulting in a net sale of 1,566,543 shares.
RxSight Inc (RXST)'s detailed insider trading history can be found in Insider Trading Tracker table.
RxSight Inc Insider Transactions
- Download to Excel(.xls)
What does Acumen Pharmaceuticals Inc do?
Who are the key executives at Acumen Pharmaceuticals Inc?
Rajeev M. Shah is the director & 10 percent owner of Acumen Pharmaceuticals Inc. Other key executives at Acumen Pharmaceuticals Inc include Chief Legal Office & Corp Sec Derek M Meisner , director & President and CEO Daniel Joseph Oconnell , and Chief Financial Officer Matt Zuga .
Acumen Pharmaceuticals Inc (ABOS) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Acumen Pharmaceuticals Inc (ABOS). Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net purchase of 5,161,290 shares made by Ra Capital Healthcare Fund Lp , a net sale of 41,949 shares made by Jeffrey L. Ives , and a net sale of 15,200 shares made by Daniel Joseph Oconnell .
In summary, during the past 3 months, insiders sold 0 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,281 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 5,161,290 shares were bought by its insiders, resulting in a net purchase of 5,085,009 shares.
Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acumen Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Viridian Therapeutics Inc do?
Who are the key executives at Viridian Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & other: See Remarks Fairmount Healthcare Fund Gp Llc , director & President and CEO Stephen F. Mahoney , and Chief Operating Officer Thomas W. Beetham .
Viridian Therapeutics Inc (VRDN) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 39,767 shares made by Lara Meisner , a net purchase of 9,500 shares made by Scott Dunseth Myers , and a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc .
In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 39,767 shares of Viridian Therapeutics Inc (VRDN) were sold and 485,690 shares were bought by its insiders, resulting in a net purchase of 445,923 shares.
Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viridian Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does WAVE Life Sciences Ltd do?
Who are the key executives at WAVE Life Sciences Ltd?
Rajeev M. Shah is the 10 percent owner of WAVE Life Sciences Ltd. Other key executives at WAVE Life Sciences Ltd include director & See Remarks Paul Bolno , See Remarks Kyle Moran , and 10 percent owner Ra Capital Healthcare Fund Lp .
WAVE Life Sciences Ltd (WVE) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in WAVE Life Sciences Ltd (WVE). Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net purchase of 2,000,000 shares made by Ra Capital Healthcare Fund Lp , a net sale of 52,692 shares made by Kyle Moran , and a net purchase of 3,300,000 shares made by Plc Glaxosmithkline .
In summary, during the past 3 months, insiders sold 48,366 shares of WAVE Life Sciences Ltd (WVE) in total and bought 0 shares, with a net sale of 48,366 shares. During the past 18 months, 101,058 shares of WAVE Life Sciences Ltd (WVE) were sold and 5,300,000 shares were bought by its insiders, resulting in a net purchase of 5,198,942 shares.
WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.
WAVE Life Sciences Ltd Insider Transactions
- Download to Excel(.xls)
What does DICE Therapeutics Inc do?
Who are the key executives at DICE Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of DICE Therapeutics Inc. Other key executives at DICE Therapeutics Inc include 10 percent owner Northpond Ventures Gp, Llc , CSO John R. Jacobsen , and director & CEO Kevin Judice .
DICE Therapeutics Inc (DICE) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in DICE Therapeutics Inc (DICE). Other recent insider transactions involving DICE Therapeutics Inc (DICE) include a net sale of 37,509 shares made by John R. Jacobsen , a net purchase of 1,007,701 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 2,492,871 shares made by Northpond Ventures Gp, Llc .
In summary, during the past 3 months, insiders sold 0 shares of DICE Therapeutics Inc (DICE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,666,925 shares of DICE Therapeutics Inc (DICE) were sold and 1,007,701 shares were bought by its insiders, resulting in a net sale of 1,659,224 shares.
DICE Therapeutics Inc (DICE)'s detailed insider trading history can be found in Insider Trading Tracker table.
DICE Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Iterum Therapeutics PLC do?
Who are the key executives at Iterum Therapeutics PLC?
Rajeev M. Shah is the 10 percent owner of Iterum Therapeutics PLC. Other key executives at Iterum Therapeutics PLC include Chief Scientific Officer Michael W. Dunne , director & President & CEO Fishman Corey N. , and Chief Medical Officer Sailaja Puttagunta .
Iterum Therapeutics PLC (ITRM) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Iterum Therapeutics PLC (ITRM). Other recent insider transactions involving Iterum Therapeutics PLC (ITRM) include a net purchase of 55,000 shares made by Michael W. Dunne , and a net purchase of 10,000 shares made by Fishman Corey N. .
In summary, during the past 3 months, insiders sold 0 shares of Iterum Therapeutics PLC (ITRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Iterum Therapeutics PLC (ITRM) were sold and 65,000 shares were bought by its insiders, resulting in a net purchase of 65,000 shares.
Iterum Therapeutics PLC (ITRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iterum Therapeutics PLC Insider Transactions
- Download to Excel(.xls)
What does Orchard Therapeutics PLC do?
Who are the key executives at Orchard Therapeutics PLC?
Rajeev M. Shah is the 10 percent owner of Orchard Therapeutics PLC. Other key executives at Orchard Therapeutics PLC include director & See Remarks Bobby Gaspar , 10 percent owner & other: See Remark 1 Fmr Llc , and 10 percent owner Ra Capital Healthcare Fund Lp .
Orchard Therapeutics PLC (ORTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Orchard Therapeutics PLC (ORTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orchard Therapeutics PLC (ORTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Orchard Therapeutics PLC (ORTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Orchard Therapeutics PLC Insider Transactions
- Download to Excel(.xls)
What does Eliem Therapeutics Inc do?
Who are the key executives at Eliem Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Eliem Therapeutics Inc. Other key executives at Eliem Therapeutics Inc include Chief Scientific Officer Valerie Morisset , director & 10 percent owner Ra Capital Healthcare Fund Lp , and Chief Accounting Officer Emily Pimblett .
Eliem Therapeutics Inc (ELYM) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Eliem Therapeutics Inc (ELYM). Other recent insider transactions involving Eliem Therapeutics Inc (ELYM) include a net sale of 481,639 shares made by Valerie Morisset , a net purchase of 13,008,546 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 1,245 shares made by Emily Pimblett .
In summary, during the past 3 months, insiders sold 482,884 shares of Eliem Therapeutics Inc (ELYM) in total and bought 13,008,546 shares, with a net purchase of 12,525,662 shares. During the past 18 months, 482,884 shares of Eliem Therapeutics Inc (ELYM) were sold and 13,008,546 shares were bought by its insiders, resulting in a net purchase of 12,525,662 shares.
Eliem Therapeutics Inc (ELYM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eliem Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Werewolf Therapeutics Inc do?
Who are the key executives at Werewolf Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Technology Officer Chulani Karunatilake , and Chief Operating Officer Reid Leonard .
Werewolf Therapeutics Inc (HOWL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Werewolf Therapeutics Inc (HOWL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Werewolf Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Icosavax Inc do?
Who are the key executives at Icosavax Inc?
Rajeev M. Shah is the director & 10 percent owner of Icosavax Inc. Other key executives at Icosavax Inc include director & Chief Executive Officer Adam K. Simpson , Chief Medical Officer Niranjan Kanesa-thasan , and Chief Financial Officer Thomas Joseph Russo .
Icosavax Inc (ICVX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Icosavax Inc (ICVX). Other recent insider transactions involving Icosavax Inc (ICVX) include a net sale of 33,581 shares made by Cassia Cearley , a net sale of 193,993 shares made by Adam K. Simpson , and a net sale of 36,799 shares made by Douglas Holtzman .
In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 297,829 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 297,829 shares.
Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Icosavax Inc Insider Transactions
- Download to Excel(.xls)
What does Aerovate Therapeutics Inc do?
Who are the key executives at Aerovate Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Aerovate Therapeutics Inc. Other key executives at Aerovate Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , See Remarks George A Eldridge , and SENIOR VICE PRESIDENT & CMC Marinus Verwijs .
Aerovate Therapeutics Inc (AVTE) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Aerovate Therapeutics Inc (AVTE). Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 162,566 shares made by Benjamin T Dake , a net sale of 68,255 shares made by Hunter Gillies , and a net sale of 108,142 shares made by Timothy P Noyes .
In summary, during the past 3 months, insiders sold 31,600 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 928,110 shares, with a net purchase of 896,510 shares. During the past 18 months, 479,600 shares of Aerovate Therapeutics Inc (AVTE) were sold and 928,110 shares were bought by its insiders, resulting in a net purchase of 448,510 shares.
Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerovate Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does POINT Biopharma Global Inc do?
Who are the key executives at POINT Biopharma Global Inc?
Rajeev M. Shah is the director of POINT Biopharma Global Inc. Other key executives at POINT Biopharma Global Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Gp Holdings Llc .
POINT Biopharma Global Inc (PNT) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in POINT Biopharma Global Inc (PNT). Other recent insider transactions involving POINT Biopharma Global Inc (PNT) include a net sale of 17,161,278 shares made by Biotechnology Value Fund L P ,
In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc (PNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,161,278 shares of POINT Biopharma Global Inc (PNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,161,278 shares.
POINT Biopharma Global Inc (PNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
POINT Biopharma Global Inc Insider Transactions
- Download to Excel(.xls)
What does Vor Biopharma Inc do?
Who are the key executives at Vor Biopharma Inc?
Rajeev M. Shah is the director & 10 percent owner of Vor Biopharma Inc. Other key executives at Vor Biopharma Inc include Chief Medical Officer Eyal C. Attar , director & 10 percent owner Kush Parmar , and 10 percent owner 5am Ventures Vi, L.p. .
Vor Biopharma Inc (VOR) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Vor Biopharma Inc (VOR). Other recent insider transactions involving Vor Biopharma Inc (VOR) include a net sale of 14,645 shares made by Eyal C. Attar ,
In summary, during the past 3 months, insiders sold 14,645 shares of Vor Biopharma Inc (VOR) in total and bought 0 shares, with a net sale of 14,645 shares. During the past 18 months, 14,645 shares of Vor Biopharma Inc (VOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,645 shares.
Vor Biopharma Inc (VOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vor Biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does Janux Therapeutics Inc do?
Who are the key executives at Janux Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include director & 10 percent owner Jay Lichter , 10 percent owner Avalon Ventures Xi, L.p. , and 10 percent owner & Acting Chief Financial Officer Tighe Reardon .
Janux Therapeutics Inc (JANX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 650,146 shares made by Avalon Ventures Xi, L.p. , a net sale of 650,146 shares made by Jay Lichter , and a net purchase of 27,133 shares made by Tighe Reardon .
In summary, during the past 3 months, insiders sold 3,822,721 shares of Janux Therapeutics Inc (JANX) in total and bought 0 shares, with a net sale of 3,822,721 shares. During the past 18 months, 3,822,721 shares of Janux Therapeutics Inc (JANX) were sold and 3,044,570 shares were bought by its insiders, resulting in a net sale of 778,151 shares.
Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Janux Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Cytek Biosciences Inc do?
Who are the key executives at Cytek Biosciences Inc?
Rajeev M. Shah is the director of Cytek Biosciences Inc. Other key executives at Cytek Biosciences Inc include director & Chief Technology Officer Ming Yan , Chief Financial Officer Patrick Jeanmonod , and director & President and CEO Wenbin Jiang .
Cytek Biosciences Inc (CTKB) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Cytek Biosciences Inc (CTKB). Other recent insider transactions involving Cytek Biosciences Inc (CTKB) include a net sale of 261,900 shares made by Ming Yan , a net sale of 33,000 shares made by Patrick Jeanmonod , and a net sale of 180,000 shares made by Wenbin Jiang .
In summary, during the past 3 months, insiders sold 0 shares of Cytek Biosciences Inc (CTKB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 474,900 shares of Cytek Biosciences Inc (CTKB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 474,900 shares.
Cytek Biosciences Inc (CTKB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytek Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does PepGen Inc do?
Who are the key executives at PepGen Inc?
Rajeev M. Shah is the director & 10 percent owner of PepGen Inc. Other key executives at PepGen Inc include See Remarks Michelle L Mellion , See Remarks Niels Svenstrup , and director & 10 percent owner Ra Capital Healthcare Fund Lp .
PepGen Inc (PEPG) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in PepGen Inc (PEPG). Other recent insider transactions involving PepGen Inc (PEPG) include a net sale of 50,000 shares made by Michelle L Mellion , a net sale of 29,556 shares made by James G Mcarthur , and a net purchase of 2,557,593 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 50,000 shares of PepGen Inc (PEPG) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 91,642 shares of PepGen Inc (PEPG) were sold and 2,559,287 shares were bought by its insiders, resulting in a net purchase of 2,467,645 shares.
PepGen Inc (PEPG)'s detailed insider trading history can be found in Insider Trading Tracker table.
PepGen Inc Insider Transactions
- Download to Excel(.xls)
What does Tyra Biosciences Inc do?
Who are the key executives at Tyra Biosciences Inc?
Rajeev M. Shah is the director & 10 percent owner of Tyra Biosciences Inc. Other key executives at Tyra Biosciences Inc include Chief Operating Officer Daniel Bensen , director & Chief Executive Officer Todd Harris , and 10 percent owner Mva Investors, Llc .
Tyra Biosciences Inc (TYRA) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Tyra Biosciences Inc (TYRA). Other recent insider transactions involving Tyra Biosciences Inc (TYRA) include a net sale of 280,000 shares made by Daniel Bensen , and a net sale of 252,175 shares made by Todd Harris .
In summary, during the past 3 months, insiders sold 3,702 shares of Tyra Biosciences Inc (TYRA) in total and bought 0 shares, with a net sale of 3,702 shares. During the past 18 months, 532,175 shares of Tyra Biosciences Inc (TYRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 532,175 shares.
Tyra Biosciences Inc (TYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tyra Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include 10 percent owner Ra Capital Healthcare Fund Lp , 10 percent owner Adjuvant Global Health Technology Fund De, L.p. , and Chief Strategy Officer Kevin Michael Krause .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 223,880 shares made by Kabeer Aziz , a net sale of 223,880 shares made by Adjuvant Global Health Technology Fund De, L.p. , and a net sale of 1,747,316 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 3,525,094 shares of AN2 Therapeutics Inc (ANTX) in total and bought 1,500,000 shares, with a net sale of 2,025,094 shares. During the past 18 months, 4,090,725 shares of AN2 Therapeutics Inc (ANTX) were sold and 3,287,778 shares were bought by its insiders, resulting in a net sale of 802,947 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include Controller Greg Tourangeau , director & See Remarks Alex Sapir , and Chief Financial Officer Alan A Musso .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 5,330 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .
In summary, during the past 3 months, insiders sold 0 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,330 shares of Fulcrum Therapeutics Inc (FULC) were sold and 43,360 shares were bought by its insiders, resulting in a net purchase of 38,030 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Rajeev M. Shah is the director of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and director & 10 percent owner & other: * Director by deputization Deerfield Management Company, L.p. (series C) .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Acrivon Therapeutics Inc do?
Who are the key executives at Acrivon Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Acrivon Therapeutics Inc. Other key executives at Acrivon Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Legal Officer Mary Miller , and director & President and CEO Peter Blume-jensen .
Acrivon Therapeutics Inc (ACRV) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Acrivon Therapeutics Inc (ACRV). Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net sale of 7,965 shares made by Chione Ltd , and a net purchase of 2,353,000 shares made by Perceptive Life Sciences Master Fund Ltd .
In summary, during the past 3 months, insiders sold 0 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,965 shares of Acrivon Therapeutics Inc (ACRV) were sold and 2,353,000 shares were bought by its insiders, resulting in a net purchase of 2,345,035 shares.
Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acrivon Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does ARS Pharmaceuticals Inc do?
Who are the key executives at ARS Pharmaceuticals Inc?
Rajeev M. Shah is the director of ARS Pharmaceuticals Inc. Other key executives at ARS Pharmaceuticals Inc include 10 percent owner & Chief Medical Officer Sarina Tanimoto , Chief Operating Officer Brian Dorsey , and director & 10 percent owner & President and CEO Richard E Lowenthal .
ARS Pharmaceuticals Inc (SPRY) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in ARS Pharmaceuticals Inc (SPRY). Other recent insider transactions involving ARS Pharmaceuticals Inc (SPRY) include a net sale of 1,203,260 shares made by Sarina Tanimoto , a net sale of 1,203,260 shares made by Richard E Lowenthal , and a net sale of 543,896 shares made by Laura Shawver .
In summary, during the past 3 months, insiders sold 2,839,864 shares of ARS Pharmaceuticals Inc (SPRY) in total and bought 0 shares, with a net sale of 2,839,864 shares. During the past 18 months, 4,790,280 shares of ARS Pharmaceuticals Inc (SPRY) were sold and 8,937,557 shares were bought by its insiders, resulting in a net purchase of 4,147,277 shares.
ARS Pharmaceuticals Inc (SPRY)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARS Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Enliven Therapeutics Inc do?
Who are the key executives at Enliven Therapeutics Inc?
Rajeev M. Shah is the 10 percent owner of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include director & President and CEO Samuel Kintz , director & Chief Scientific Officer Joseph P Lyssikatos , and Chief Financial Officer Benjamin Hohl .
Enliven Therapeutics Inc (ELVN) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 181,979 shares made by Samuel Kintz , a net sale of 165,099 shares made by Joseph P Lyssikatos , and a net sale of 58,741 shares made by Benjamin Hohl .
In summary, during the past 3 months, insiders sold 152,404 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 152,404 shares. During the past 18 months, 4,673,620 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,673,620 shares.
Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enliven Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Mineralys Therapeutics Inc do?
Who are the key executives at Mineralys Therapeutics Inc?
Rajeev M. Shah is the director & 10 percent owner of Mineralys Therapeutics Inc. Other key executives at Mineralys Therapeutics Inc include 10 percent owner Catalys Pacific Fund, Lp , Chief Medical Officer David Malcom Rodman , and director & Chief Executive Officer Jon Congleton .
Mineralys Therapeutics Inc (MLYS) Insider Trades Summary
Over the past 18 months, Rajeev M. Shah made no insider transaction in Mineralys Therapeutics Inc (MLYS). Other recent insider transactions involving Mineralys Therapeutics Inc (MLYS) include a net sale of 127,106 shares made by Jon Congleton , a net sale of 232,341 shares made by David Malcom Rodman , and a net sale of 107,572 shares made by Adam Scott Levy .
In summary, during the past 3 months, insiders sold 795,953 shares of Mineralys Therapeutics Inc (MLYS) in total and bought 0 shares, with a net sale of 795,953 shares. During the past 18 months, 1,027,769 shares of Mineralys Therapeutics Inc (MLYS) were sold and 566,305 shares were bought by its insiders, resulting in a net sale of 461,464 shares.
Mineralys Therapeutics Inc (MLYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mineralys Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
Rajeev M. Shah Mailing Address
Above is the net worth, insider trading, and ownership report for Rajeev M. Shah. You might contact Rajeev M. Shah via mailing address: 200 Berkeley Street, 18th Floor, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey